| Application no. and date | 20833822.8 (espacenet) (Federated) (European Patent Register), 20201217 | | Patent/reg. no. and date | DK/EP 4077639, 20240612 | | Publication date | 20221026 | | Priority no. and date | EP 19218724, 20191220 | | EP pub. no. and date |
EP 4077639 20221026 | | Effective date | | | Applicant/owner | Mallinckrodt Pharmaceuticals Ireland Limited, College Business & Technology Park
Cruiserath, Blanchardstown
Dublin 15, IE | | Applicant ref. no. | P84978DK01 | | Inventor | ZEISER, Robert, Lise Meitner Str. 10
79100 Freiburg, DE,
APOSTOLOVA, Petya, Hugstetterstr 50
79106 Freiburg, DE,
DUYSTER, Justus, Tennenbacher Str. 9
79106 Freiburg, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 41/00 (2020.01) , C12N 5/0783 (2010.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF IMMUNREGULATORISKE CELLER I EN BLODAFLEDT PRØVE | | Int. application no. | EP2020086733 | | Int. publication no. | WO2021122969 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
